US FDA Finds Phenylephrine Ineffective As Nasal Decongestant, Looks At Removing From Monograph
Agency Asks For NDAC Input On 'Unintended Consequences' On Consumers, Industry
Executive Summary
Phenylephrine doesn’t meet efficacy bar within “generally regarded as safe and effective” standard for OTC monograph drugs, agency says in briefing prepared for NDAC meeting on 11-12 September. FDA say it is “concerned about avoiding potential unintended consequences with regard to changing the GRASE status of oral PE.”